Jiangsu Apon Medical Technology Co Ltd Class A Cash Flow Conversion Efficiency
Jiangsu Apon Medical Technology Co Ltd Class A cash flow conversion efficiency. Based on the latest financial reports, Jiangsu Apon Medical Technology Co Ltd Class A (300753) has a cash flow conversion efficiency ratio of -0.004x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-2.69 Million ≈ $-394.26K USD) by net assets (CN¥686.08 Million ≈ $100.39 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Jiangsu Apon Medical Technology Co Ltd Class A (2014–2024)
Cash flow conversion efficiency of Jiangsu Apon Medical Technology Co Ltd Class A from 2014 to 2024. This chart illustrates how Jiangsu Apon Medical Technology Co Ltd Class A's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Jiangsu Apon Medical Technology Co Ltd C share price for real-time trading data and today's change.
Jiangsu Apon Medical Technology Co Ltd Class A Cash Flow Conversion Ratio Explained
Jiangsu Apon Medical Technology Co Ltd Class A cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Jiangsu Apon Medical Technology Co Ltd Class A Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Jiangsu Apon Medical Technology Co Ltd Class A ranked by their cash flow conversion efficiency. Also see Jiangsu Apon Medical Technology Co Ltd C market cap and net worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Girisim Elektrik Taahhut Ticaret & Sanayi AS
IS:GESAN
|
0.006x |
|
Plumas Bancorp
NASDAQ:PLBC
|
0.021x |
|
Duniec
TA:DUNI
|
-0.071x |
|
KOSES Co.Ltd
KQ:089890
|
0.044x |
|
Guangdong Huafeng New Energy Technology Co Ltd
SHE:002806
|
-0.044x |
|
Capex S.A
BA:CAPX
|
0.012x |
|
General Oceans ASA
OL:GENO
|
-0.052x |
|
Innovative Solutions and Support
NASDAQ:ISSC
|
0.119x |
Annual Cash Flow Conversion Efficiency for Jiangsu Apon Medical Technology Co Ltd Class A (2014–2024)
The table below shows the annual cash flow conversion efficiency of Jiangsu Apon Medical Technology Co Ltd Class A from 2014 to 2024. Review Jiangsu Apon Medical Technology Co Ltd C free cash flow efficiency to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥707.86 Million ≈ $103.58 Million |
CN¥15.68 Million ≈ $2.29 Million |
0.022x | +166.18% |
| 2023-12-31 | CN¥697.20 Million ≈ $102.02 Million |
CN¥-23.34 Million ≈ $-3.41 Million |
-0.033x | +6.59% |
| 2022-12-31 | CN¥686.36 Million ≈ $100.44 Million |
CN¥-24.59 Million ≈ $-3.60 Million |
-0.036x | -252.95% |
| 2021-12-31 | CN¥780.52 Million ≈ $114.21 Million |
CN¥18.29 Million ≈ $2.68 Million |
0.023x | -79.20% |
| 2020-12-31 | CN¥739.84 Million ≈ $108.26 Million |
CN¥83.34 Million ≈ $12.20 Million |
0.113x | -2.02% |
| 2019-12-31 | CN¥674.88 Million ≈ $98.76 Million |
CN¥77.59 Million ≈ $11.35 Million |
0.115x | -9.73% |
| 2018-12-31 | CN¥613.39 Million ≈ $89.76 Million |
CN¥78.13 Million ≈ $11.43 Million |
0.127x | -46.95% |
| 2017-12-31 | CN¥279.38 Million ≈ $40.88 Million |
CN¥67.08 Million ≈ $9.82 Million |
0.240x | -9.59% |
| 2016-12-31 | CN¥229.59 Million ≈ $33.60 Million |
CN¥60.97 Million ≈ $8.92 Million |
0.266x | +1.41% |
| 2015-12-31 | CN¥145.40 Million ≈ $21.28 Million |
CN¥38.08 Million ≈ $5.57 Million |
0.262x | -36.37% |
| 2014-12-31 | CN¥81.37 Million ≈ $11.91 Million |
CN¥33.49 Million ≈ $4.90 Million |
0.412x | -- |
About Jiangsu Apon Medical Technology Co Ltd Class A
Jiangsu Apon Medical Technology Co., Ltd. engages in the research and development, production, and sale of medical devices in China. The company's principal products include microcomputer injection pumps, disposable injection pumps, wireless analgesia management systems, and pulse oximeters, as well as medical devices, such as sensors in the field of pain management and nasal care sprayers. Jiang… Read more